Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Asymptomatic seroconversion in healthy people against dengue and chikungunya in Kandy district of Sri Lanka

View ORCID ProfileL.E.A.D.A. Edirisinghe, T.A.N. Mahakapuge, S.A.M. Kularatne, S.A.M.D.A. Kularatne, R.P.V.J. Rajapakse
doi: https://doi.org/10.1101/2024.04.18.24306054
L.E.A.D.A. Edirisinghe
1Department of Pathobilogy, Faculty of Veterinary Medicine and Animal Science, University of Peradeniya, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L.E.A.D.A. Edirisinghe
  • For correspondence: diliniedirisinghe243{at}gmail.com
T.A.N. Mahakapuge
1Department of Pathobilogy, Faculty of Veterinary Medicine and Animal Science, University of Peradeniya, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.A.M. Kularatne
2Department of Medicine, Faculty of Medicine, University of Peradeniya, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.A.M.D.A. Kularatne
3Faculty of Medicine, University of Peradeniya, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.P.V.J. Rajapakse
1Department of Pathobilogy, Faculty of Veterinary Medicine and Animal Science, University of Peradeniya, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Both dengue and chikungunya are transmitted by Aedes aegypti and have many similarities in epidemiology and clinical manifestations. These two viruses are known to cause asymptomatic infection, however, studies to assess the seroprevalence in healthy individuals are limited. Our objective is to estimate the asymptomatic seroconversion status of both these infections Sri Lanka where dengue has been endemic and the last notable outbreak of chikungunya occurred in 2007.

Methods The study was performed using venous blood samples of 454 healthy individuals (age range 11-78) in Kandy district, who had no known history of dengue or chikungunya infections in the past or present. Samples were tested for dengue NS1 antigen, dengue IgM, dengue IgG, Chikungunya IgM and Chikungunya IgG by using commercially available ELISA kits. Statistical data analysis was performed using SPSS software version 16.0 (SPSS, Inc., Chicago, IL, USA). P value <0.05 was considered statistically significant.

Results Of the 454 healthy individuals, 287 (63.2%) were positive for dengue IgG indicating a past infection and 18 (4%) were positive for dengue-specific IgM. Of the same total, 82 (18.1%) were positive chikungunya chikungunya-specific IgM and only 6 (1.3%) were positive for chikungunya-specific IgM. The number of individuals positive for both dengue IgG and Chikungunya IgG, indicating dual antibody prevalence or exposure to both diseases asymptomatically was 61(13.43%). For dengue specific IgG, the highest sero-conversion rate (80.4%) was observed in 51-60 year age group whilst the lowest (50%) in the age group 11-20. Out of the MOH areas, the highest prevalence (71.4%) of positives were observed in Bambaradeniya and the lowest prevalence (53.1%) in Yatinuwara suburbs in Kandy. The highest percentage of dengue IgM prevalence (6.3%) was observed in the age group 21-30 years and the lowest percentage (1.5%) was observed in the age group 11-20.

Conclusions An asymptomatic seroconversion rate was observed in both dengue and Chikungunya infections. Dengue records a high rate due to its endemicity and periodic outbreaks. It is interesting to note the low-grade prevalence of Chikungunya infection contrary to the belief itsnon-existence in the island currently.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by University of Peradeniya

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical clearance for this project was obtained from the Institutional Ethical Review Committee, Faculty of Medicine, University of Peradeniya

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript

  • Abbreviations

    K2EDTA-Di
    Potassium Ethylene Diammine Tetra Aciticacid.
    DF
    Dengue fever
    DSS
    Dengue Shock Syndrome
    DHF
    Dengue Hemorrhagic fever
    WBC
    White Blood Cells
    PCV
    Packed Cell Volume
    PCR
    Polymerase Chain Reaction
    WBC
    White Blood Cells
    DC
    Differential Count
    RT-PCR
    Real time polymerase chain reaction
    CHIKV
    Chikungunya virus
    DENV
    Dengue virus
    MOH
    medical Officer of Health Author contribution
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted April 19, 2024.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Asymptomatic seroconversion in healthy people against dengue and chikungunya in Kandy district of Sri Lanka
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Asymptomatic seroconversion in healthy people against dengue and chikungunya in Kandy district of Sri Lanka
    L.E.A.D.A. Edirisinghe, T.A.N. Mahakapuge, S.A.M. Kularatne, S.A.M.D.A. Kularatne, R.P.V.J. Rajapakse
    medRxiv 2024.04.18.24306054; doi: https://doi.org/10.1101/2024.04.18.24306054
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Asymptomatic seroconversion in healthy people against dengue and chikungunya in Kandy district of Sri Lanka
    L.E.A.D.A. Edirisinghe, T.A.N. Mahakapuge, S.A.M. Kularatne, S.A.M.D.A. Kularatne, R.P.V.J. Rajapakse
    medRxiv 2024.04.18.24306054; doi: https://doi.org/10.1101/2024.04.18.24306054

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)